HAVCR2 and neoplasm: Moreover, acquired resistance to immunotherapy was associated with the PD-1/TIM-3 double-positive exhausted T-cell phenotype in tumor bed and this phenomenon was further abrogated by adding anti-VEGF targeted agents, thus highlighting a potential role of anti-VEGF agents in reverting secondary resistance to immunotherapy.